TG Therapeutics Operating Income 2010-2024 | TGTX

TG Therapeutics operating income for the twelve months ending December 31, 2024 was $0.042B, a 103.21% increase year-over-year.

  • TG Therapeutics annual operating income for 2024 was $0.042B, a 103.21% increase from 2023.
  • TG Therapeutics annual operating income for 2023 was $0.021B, a 109.45% decline from 2022.
  • TG Therapeutics annual operating income for 2022 was $-0.218B, a 36.68% decline from 2021.

TG Therapeutics Operating Income 2010-2024 | TGTX

  • TG Therapeutics annual operating income for 2024 was $0.042B, a 103.21% increase from 2023.
  • TG Therapeutics annual operating income for 2023 was $0.021B, a 109.45% decline from 2022.
  • TG Therapeutics annual operating income for 2022 was $-0.218B, a 36.68% decline from 2021.